Role of the tumor microenvironment in tumor progression and the clinical applications (Review)

Cited by (321)

Items 201–300 of 321

1. Carcinogenic effects of paraquat-based herbicides: a comprehensive review
   Mercedes García Carrillo, Daniela Madanes, Matı́as Blaustein · 2025 · Environmental Science and Pollution Research
2. Quinazoli-4-one ionic liquid as a fluorescent sensor for NH3 detection: Interaction with ctDNA, theoretical investigation and live cell bioimaging
   Ananya Srivastava, Gautam Kumar, Prabhat Kumar, S. Srikrishna, Vinod Prasad Singh · 2023 · International Journal of Biological Macromolecules
3. Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers
   Yu Chang, Shiyong Li, Zhiming Li, Xinhua Wang, Fangyuan Chang, Shuaipeng Geng, Dandan Zhu, Guolin Zhong, Wei Wu, Yinyin Chang et al. · 2024 · Frontiers in Oncology
4. Decoding the synergistic potential of MAZ‐51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals
   Kganya Letsoalo, Evangeline Nortjé, Sean Mark Patrick, Trevor Tapiwa Nyakudya, Yvette Nkondo Hlophe · 2024 · Cell Biochemistry and Function
5. Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
   Um‐e‐Kalsoom, Shiqi Wang, Junle Qu, Liwei Liu · 2024 · Cancer Medicine
6. Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
   Margarite D. Matossian, Alexandra A. Giardina, Maryl K. Wright, Steven G. Elliott, Michelle Marie Loch, Khoa Nguyen, Arnold H. Zea, Frank H. Lau, Krzysztof Moroz, Adam I. Riker et al. · 2020 · Women s Health Reports
7. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
   Xiaojie Liang, Ruiying Fu, He-nan Wang, Jing Yang, Na Yao, Xindi Liu, Liang Wang · 2021 · Journal of Immunology Research
8. Heterogeneous effects of M‐ CSF isoforms on the progression of MLL ‐ AF 9 leukemia
   Rong Wang, Wenli Feng, Feifei Yang, Xiao Qi Yang, Lina Wang, Chong Chen, Yuting Hu, Qian Ren, Guoguang Zheng · 2017 · Immunology and Cell Biology
9. Immunological and vascular characteristics in cavernous sinus meningioma
   Kenzo Kosugi, Ryota Tamura, Kentaro Ohara, Yukina Morimoto, Yuki Kuranari, Yumiko Oishi, Kazunari Yoshida, Masahiro Toda · 2019 · Journal of Clinical Neuroscience
10. Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
    Yurong Song, Travis D. Kerr, Chelsea Sanders, Lisheng Dai, Shaneen S. Baxter, Brandon Somerville, Ryan N. Baugher, Stephanie D. Mellott, Todd B. Young, Heidi E. Lawhorn et al. · 2023 · Frontiers in Oncology
11. Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip
    Pooja Suryavanshi, Dhananjay Bodas · 2024 · Nanotheranostics
12. Machine learning predictions of tumor progression: How reliable are we?
    Molham Sakkal, Abdallah Abou Hajal · 2025 · Computers in Biology and Medicine
13. Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma
    Yong‐Moon Lee, Min‐Kyung Yeo, In‐Ock Seong, Kyung‐Hee Kim · 2018 · Anticancer Research
14. Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
    Aida Raigón Ponferrada, José Luis Guerrero Orriach, Alfredo Malo-Manso, Enrique Sepúlveda Haro, Salvador Romero Molina, Ana Fontaneda Heredia, Manolo Baena Lopez, José Cruz Mañas · 2020 · ecancermedicalscience
15. Cancer chemoresistance and therapeutic strategies targeting tumor microenvironment
    Gayathri Heenatigala Palliyage, Rajib Ghosh, Yon Rojanasakul · 2020 · ScienceAsia
16. Pan-cancer analysis of PSAP identifies its expression and clinical relevance in gastric cancer
    Zhenpeng Wen, Chunjiao Yang, Dan Zou, Jiaqing Liu, Song Wang, Xuqin Liu, Yi Zhang, Ye Zhang · 2022 · Pathology - Research and Practice
17. 3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells
    Ju‐Hyun An, Woo‐Jin Song, Qiang Li, Dong Ha Bhang, Hwa‐Young Youn · 2021 · Journal of Veterinary Science
18. Disrupting stromal barriers to enhance photothermal-chemo therapy using a halofuginone-loaded Janus mesoporous nanoplatform
    Rui Tang, Meng Dang, Xiaojun Zhang, Jun Tao, Wenhui Shi, Wei Ming Lu, Ruifa Yu, Xiaodan Su, Yuxia Tang, Zhaogang Teng · 2021 · Journal of Colloid and Interface Science
19. Receptor, Signal, Nucleus, Action: Signals That Pass through Akt on the Road to Head and Neck Cancer Cell Migration
    Albashir Alzawi, Anem Iftikhar, Basher Shalgm, Sarah Jones, Ian Ellis, Mohammad R Islam · 2022 · Cancers
20. SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma
    Bin Li, Meiyu Ren, Yuzhen Chen, Yuqi Meng, Tie‐Niu Song, Zhipeng Su, Bo Yang · 2022 · The Journal of Gene Medicine
21. Strategies for cancer therapy
    Abeer Hamed Abdel-Halim · 2023 · Egyptian Pharmaceutical Journal
22. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast
    Sneha Pandithar, Daniel Galke, Ahone Akume, Artem Belyakov, Dominick Lomonaco, Amirah A. Guerra, Jay Park, Olivia Reff, Kideok Jin · 2024 · Molecular Biology Reports
23. A novel approach for transforming breast cancer stem cells into endothelial cells
    Qi-Qi Mao, Xiao-Chun Ji, Jianan Zhang, Wei-Feng Teng, Shaocheng Zhou · 2023 · Experimental and Therapeutic Medicine
24. Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model
    Abdulmohammad Pezeshki, John C. Cheville, Angela B. Florio, Bradley C. Leibovich, George Vasmatzis · 2024 · Frontiers in Immunology
25. Tensile force field plays a crucial role in local invasion of tumor cells through a mechano-chemical coupling mechanism
    Jianfeng Meng, Xiangyu Xu, Chaohui Jiang, Peng Xia, Pengfei Xu, Liangfei Tian, Yingke Xu, Dechang Li, Youhua Tan, Baohua Ji · 2024 · Soft Matter
26. The epidermal integrin-mediated secretome regulates the skin microenvironment during tumorigenesis and repair
    Whitney M. Longmate · 2024 · Matrix Biology
27. The effect of cancer cell-derived exosomal proteins on macrophage polarization: An in-depth review
    Khandu Wadhonkar, Soumalya Das, R. Subramanian, Mobbassar Hassan Sk, Yashi Singh, Mirza S. Baig · 2024 · Experimental Cell Research
28. Single-cell transcriptomic analyses provide insights into the tumor microenvironment heterogeneity and invasion phenotype in retinoblastoma
    Xiaoliang Zhang, Hong Liu, Zhida Lan, Guangping Gao, Guanyu Li, Ziwei Dai, Shangyao Qin, Wei Shen · 2025 · Pathology - Research and Practice
29. Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma
    Yingyi Wang, Bao Jin, Na Zhou, Zhao Sun, Jiayi Li, Qiao Chen, Xiangan Wu, Yi Zhou, Yue Xi Shi, Xin Lu et al. · 2020 · Current Cancer Drug Targets
30. Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer
    Xingling Wang, Jing Wang, Mingxin Yu · 2022 · Computational and Mathematical Methods in Medicine · Retracted
31. ImReLnc: Identifying Immune-Related LncRNA Characteristics in Human Cancers Based on Heuristic Correlation Optimization
    Meihong Gao, Shuhui Liu, Qi Yang, Xinpeng Guo, Xuequn Shang · 2022 · Frontiers in Genetics
32. Tumor Suppressor miR-613 Alleviates Non-Small Cell Lung Cancer Cell via Repressing M2 Macrophage Polarization
    Mingjun Yang, Wen Zhou, Mingming Xu, Xiao Lian Han, Yanyan Shi, Min Shi, Zhipeng Wang · 2023 · Journal of Oncology
33. An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment
    Sibin Mei, Chenhao Bai, Huijuan Wang, Kainan Lin, Tianyuan Pan, Yunkun Lu, Qian Cao · 2025 · Biomedicines
34. A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
    Karina Benderski, Paul M. Schneider, Panayiotis Kordeves, Michael Fichter, Jenny Schunke, Federica De Lorenzi, Feyza Durak, Barbara Schrörs, Özlem Akilli‐Öztürk, Fabian M. Kiessling et al. · 2024 · Pharmacological Research
35. Dauriporphine inhibited lung cancer cell viability, motility, and energy metabolism through the miR-424-5p/MAPK14 axis
    Yanjia Du, Jinpeng Lv, Yao Shi Fu, Meng Lan, Jingfeng Li, Hui Zhang, Nan Wu · 2025 · Hereditas
36. The Role of Fibroblasts in Melanoma Development: From Tumor Microenvironment Remodeling to Pre-Metastatic Niche Formation
    Immacolata Belviso, Raffaele Pastore, Aldo Mileo, Emiliano Del Genio, Stefania Boccia, Stefano Palermi, Carmine Sellitto, Maria Letizia Motti · 2025 · International Journal of Molecular Sciences
37. Transcriptomic analysis of stromal cells from patients with endometrial carcinoma.
    Min Li, Xiaoyan Xin, Zhishan Jin, Hua Teng, Hongbin Wang, Hongbo Wang · 2017 · PubMed Central
38. Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability
    Yurong Song, Shaneen S. Baxter, Lisheng Dai, Chelsea Sanders, Sandra Sczerba Burkett, Ryan N. Baugher, Stephanie D. Mellott, Todd B. Young, Heidi E. Lawhorn, Simone Difilippantonio et al. · 2022 · Cancers
39. Hepatoma cell-derived exosomal SNORD52 mediates M2 macrophage polarization by activating the JAK2/STAT6 pathway
    Yaqiong Zhang, Bo Li, Wanhong Gu, Linna Fan, Xiao‐Fan Wang, Meifen Xu, Minqi Zhu, Chong Jin · 2025 · Discover Oncology
40. Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting
    Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, Giuliana Salvatore, Maria Letizia Motti · 2025 · Cancers
41. Lipoproteins and the Tumor Microenvironment
    Akpedje Serena Dossou, Nirupama A. Sabnis, Bhavani Nagarajan, Ezek Mathew, Rafał Fudala, Andras G. Lacko · 2020 · Advances in experimental medicine and biology
42. Dual therapeutic strategy targeting tumor cells and tumor microenvironment in triple-negative breast cancer
    Tsu‐Yi Chao, Pamungkas Bagus Satriyo, Chi‐Tai Yeh, Jia-Hong Chen, Teguh Aryandono, Sofia Mubarika Haryana · 2020 · Journal of Cancer Research and Practice
43. Targeting tumor microenvironment for breast cancer treatment
    Manzoor Ahmad Mir, Burhan Ul Haq · 2022 · Elsevier eBooks
44. Factors affecting heterogeneity in breast cancer microenvironment: A narrative mini review
    Anirban Ganguly, Sumit Mukherjee, Kaushiki Chatterjee, Sheila Spada · 2024 · International review of cytology
45. Antineoplastic drug‐loaded polymer‐modified magnetite nanoparticles: Comparative analysis of EPR‐mediated drug delivery
    Amaneh Javid, Madiha Javeed Ghani, Sughra Shahzad, Saeed Rezaei‐Zarchi · 2020 · Cell Biology International
46. CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
    Sayan Mullick Chowdhury, Feng Hong, Christian Diego Rolfo, Zihai Li, Kai He, Robert Wesolowski, Amir Mortazavi, Lingbin Meng · 2025 · Biology
47. Tumor Microenvironment in Cancer Biology: A Comprehensive Review of Stromal, Immune, and Vascular Components Driving Malignancy
    Sushma T A, Sudarshan Gupta, Priyanka Kiyawat, Yashodha Darshan, Kumar Sambhav, Saiyad Shabbirali Shamshadali · 2025 · Cureus
48. Regular Voluntary Running is Associated with Increased Tumor Vascularization and Immune Cell Infiltration and Decreased Tumor Growth in Mice
    Mário Esteves, Carina Silva, António Bovolini, Sofia Silva Pereira, Tiago Morais, Ângela Moreira, Madalena M Costa, Mariana Pereira Monteiro, José Alberto Duarte · 2023 · International Journal of Sports Medicine
49. Tumour immune microenvironment as the origin of heterotypic circulating tumour cell clusters and their impact on metastasis: An hypothesis
    Geeta S. Boora, Anshika Chauhan, Arnab Pal · 2023 · Medical Hypotheses
50. Thermo-Responsive Hydrogel Based on Lung Decellularized Extracellular Matrix for 3D Culture Model to Enhance Cancer Stem Cell Characteristics
    Lei Chen, Fanglu Li, Ruobing Li, Ke Zheng, Xinyi Zhang, Huijing Ma, Kaiming Li, Lei Nie · 2024 · Molecules
51. Polymeric mixed micelles with triple stimuli-responsive characteristics and förster resonance energy transfer phenomenon for drug delivery system of chemotherapy and photodynamic therapy
    Hong‐Jia Lin, Li-Xuan Hong, Wen‐Chung Wu · 2025 · Journal of Polymer Research
52. High-Throughput Microenvironment Microarray (MEMA) High-Resolution Imaging
    Tiina A. Jokela, Michael E. Todhunter, Mark A. LaBarge · 2022 · Methods in molecular biology
53. The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma
    Myung-Jin Lee, Dokyeong Kim · 2022 · Asian Pacific Journal of Cancer Prevention
54. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Cancers
    Prince Amoah Barnie, Justice Afrifa, Eric Ofori Gyamerah, Benjamin Amoani · 2022 · Physiology
55. A primer on metabolic contributions in tumor angiogenic microenvironment
    Ma Carmen Ocaña, Manuel Bernal, Ana R. Quesada, Miguel Ángel Medina · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
56. Bacterial extracellular vesicle technology for precision cancer medicine: Biotechnological advances and applications
    Xiang Gao, Wenzhao Wang, Mingjie Sun, Hongxiang Zhao, Zhuo Shang, Alice S.T. Wong, Yunshan Wang, Miaoqing Zhao, Duanrui Liu · 2026 · Biomedical Technology
57. Reprogramming of Tumor Associated Immune Cells by Phytochemicals: In-vitro Approaches for Cancer Treatment
    Pradip Kumar Jaiswara, Vishal Kumar Gupta, Shiv Govind Rawat, Pratishtha Sonker, Ajay Kumar · 2019 · Springer eBooks
58. Spheroids of FAP-Positive Cell Lines as a Model for Screening Drugs That Affect FAP Expression
    Victor V. Pleshkan, Marina V. Zinovyeva, Dina V. Antonova, И. В. Алексеенко · 2023 · Biomedicines
59. Correlation of Radiomics with Treatment Response in Liver Metastases
    Leila Mostafavi, Fatemeh Homayounieh, Félix Lades, Andrew N. Primak, Victorine V. Muse, Gordon J. Harris, Mannudeep K. Kalra, Subba Rao Digumarthy · 2023 · Academic Radiology
60. DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma
    Cuixian Li, Xiaoling Zhu · 2024 · Heliyon
61. Vol 15 Issue 1 Tumor Microenvironment-Different Cells and Functions in the Metastasis and Progression of Cancer
    Maryam Musleh Althobiti · 2024 · International Journal of Pharmaceutical Investigation
62. Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer
    Hye Sung Won, Yong-Seok Kim, Kyung Jin Seo, Sun‐Young Jun, Der Sheng Sun, Mihong Choi, Jung‐Sook Yoon, Jae Ho Byun · 2025 · Frontiers in Oncology
63. The role of the tumor microenvironment in the metastasis of pancreatic cancer and immunotherapy
    Şermin Tetik, Nilgün Tekkeşin · 2019 · Elsevier eBooks
64. Roles for Integrin α3β1 in Development and Disease
    C. Michael DiPersio, Whitney M. Longmate · 2023 · Biology of extracellular matrix
65. Single-Cell Multiomics: Dissecting Cancer
    Janani Sambath, Krishna Patel, Sewanti Atul Limaye, Prashant Kumar · 2020 · Algorithms for intelligent systems
66. Reveal the pharmacodynamic substances and mechanism of an edible medicinal plant Platycodonis radix inhibits tumor
    Wei Wu, Chuan Cheng, Zhongmiao Wang, Dongdong Yuan, Peng Li, Le Li · 2024 · Journal of Functional Foods
67. Smart materials in pharmacological drug development: Neutrophils and its constituents for drug delivery and consequent antitumor effects
    Shengjie Cai, Xuehan Wei, Qian Li, Ziyu Jiang, Lingchang Li · 2025 · Molecular Immunology
68. Smart Nanometals: An Approach to Transform Brain Cancer Diagnosis and Therapy
    Anam Arora, Neha Jain, Manisha Pandey, Shreya Kaul, Rupali Verma, Bapi Gorain · 2025 · Molecular Pharmaceutics
69. Comparison of haematological and serum lipid profile parameters in oral potentially malignant disorders and oral squamous cell carcinoma
    Akhilesh Chandra, Rahul Kumar Agarwal, R. Keerthika, Trupti Jain, Mahesh Khairnar, Akhilesh Kumar Singh, R. Uma Maheswari · 2025 · National Journal of Maxillofacial Surgery
70. TMT1A inhibits lung adenocarcinoma progression by suppressing M2 macrophage polarization
    Junfan Pan, Qiongwen Wu, Yunan Zhao, Sixuan Wu, Liu He, Qihong Pan, Xiaohui Chen, Jing Zhang, Yiquan Xu · 2025 · iScience
71. The ESIPT-based benzothiazole chemosensor for colorimetric and fluorometric detection of ammonia, an environmental pollutant
    Prakash Seenu, Gnanesh Palani, Namrata Priyadarshini Hota, Naveen Murugan, Rishika Suresh, Dhanapal Jothi, Sathiyanarayanan Kulathu Iyer · 2025 · Journal of environmental chemical engineering
72. Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions
    R. Fonte, Isabella Bolognino, Federica Sommonte, Simona Serratì, Rossella Fasano, Ilaria Arduino, Rosa Maria Iacobazzi, Nunzio Denora, Paola Perego, Giacomina Rossi et al. · 2026 · Discover Nano
73. THE CONTRIBUTION OF LACTATE AND PHOSPHATE ANIONS TO THE BUFFER PROPERTIES OF TISSUE HOMOGENATES OF BREAST ADENOCARCINOMA
    Margarita Barsukova, Yekaterina Khomutova, Yevgeniy Khomutov · 2019 · Voprosy Onkologii
74. Intercellular interactions in the tumor stroma and their role in oncogenesis
    Nataliya A. Lunina, Dina R. Safina · 2022 · Molecular Genetics Microbiology and Virology (Russian)
75. Proteasome Subunit Alpha Type-7 Expression Suppresses Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Cancer-associated Cytokines
    X.X. Xu, Meiling Pei, Ki‐Yeol Kim, HAORAN XI, Sang Gyun Lee, Kee Yang Chung, Mi Ryung Roh, Zhehu Jin · 2023 · In Vivo
76. Engineering global and local signal generators for probing temporal and spatial cellular signaling dynamics
    Haowen Yang, Jurjen Tel · 2023 · Frontiers in Bioengineering and Biotechnology
77. Inhibitory effect of recombinant tyrosine‑sulfated madanin‑1, a thrombin inhibitor, on the behavior of MDA‑MB‑231 and SKOV3 cells in vitro
    Guk Heui Jo, Sun Ah Jung, Tae Hoon Roh, Jin Sook Yoon, Joon Lee · 2024 · Molecular Medicine Reports
78. Inhibition of MCP1 (CCL2) Enhances Antitumor Activity of NK Cells Against HCC Cells Under Hypoxia
    Hwan Hee Lee, Juhui Kim, Eunbi Park, Hyojeung Kang, Hyosun Cho · 2025 · International Journal of Molecular Sciences
79. Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
    Anthony N. Audino, Mitchell Stuart Cairo · 2019 · Resistance to targeted anti-cancer therapeutics
80. ANKDD1A may serve as a critical gene in the immune microenvironment of breast cancer
    Ping Zhao, Yang Fu, Xin Ling Yang, Hiseein Ali Abdoulaye, Ritika Rauniyar, Jing Peng, Maohua Wang, Huiqiao Wang, Minjie Ning, Ying Chen et al. · 2021 · Translational Cancer Research
81. Potential use of absorbance scanning in differentiating tumor microenvironment compositions from endoscopic biopsy of colorectal cancer patients.
    Murdani Abdullah, Amanda Pitarini Utari, Saskia Aziza Nursyirwan, Dimas Ramadhian Noor · 2021 · F1000Research
82. Consistency Analysis of CTLM Imaging and Mammography in the Diagnosis of Breast Tumor Lesions
    Zhangjun Song, Huxia Wang, Xiaorui Feng, Xiaomin Yang, Pihua Han, Jing Zhao · 2022 · Journal of Healthcare Engineering · Retracted
83. RETRACTED ARTICLE: Development of new c-Met inhibitors and application of corresponding multitarget tyrosine kinase inhibitors in tumor therapy
    Xiangcong Zeng, Yuanwen Hu, Zhi Peng Xu, Xiaoyu O. Wu, Yun Xiong, Shengpeng Liu · 2023 · Soft Computing · Retracted
84. CHEMOTHERAPY-INDUCED PDL-1 EXPRESSION IN CANCER-ASSOCIATED FIBROBLASTS PROMOTES CHEMORESISTANCE IN NSCLC
    Gayathri Heenatigala Palliyage · 2023
85. MATHEMATICAL MODELING AND OPTIMIZATION OF TARGETED TUMOR THERAPY
    Aleksey Bogdanov · 2018 · Practical oncology
86. Importancia de la investigación sobre el estroma tumoral en el cáncer de mama
    Noemí Eiró, Sandra Cid, María Fraile, Francisco José Vizoso · 2019 · Revista de Senología y Patología Mamaria
87. Development of artificial cell culture platforms using microfluidics
    Hande Karamahmutoğlu · 2019 · Sabanci University
88. Variable Tumor Microenvironment-on-a-chip with Temporal Angiogenic Switching System by Diffusion Control
    SungHyun Cho, Hyung Seok Choi, Jung Eun Yang, SeungBeum Suh · 2020 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
89. Strategies for targeted and image-guided drug delivery to tumor
    Ayele H. Negussie · 2021
90. Papel de ADAMTS-1 nuclear em células normais e tumorais.
    Suély Vieira da Silva · 2020
91. SYNGR2 Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Esophageal Squamous Cell Carcinoma
    Bin Li, Meiyu Ren, Yuzhen Chen, Yuqi Meng, Tie‐Niu Song, Zhipeng Su, Bo Yang · 2022 · Research Square
92. Faculty Opinions recommendation of Roles of circRNAs in the tumour microenvironment.
    Sabine Müller · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
93. Designing injectable and autoclavable cryogel scaffolds for tissue engineering and tumor/tissue reconstruction
    Mahboobeh Rezaeeyazdi · 2019
94. Functional roles of EMP-associated targets in breast cancer models
    Alan Kie Leong Toh · 2021 · Queensland University of Technology
95. Tumor Associated Macrophages: Evolutionary Role in Cancer Therapeutics
    Fouzia Fazal, Muhammad Arsalan Khan, Sumayya Shawana, Muhammed Mubarak · 2022 · Journal of Bahria University Medical and Dental College
96. Resposta do tratamento com metformina e do exercício físico aeróbio na mitigação dos distúrbios musculares induzidos pela doxorrubicina.
    Edson Alves de Lima · 2020
97. Prognostic significance of Cyclooxygenase-2 expression in colorectal adenoma and Adenocarcinoma: A clinicopathologic study
    Noor I. Ibrahim, Shazana Hilda Shamsuddin, Suk K. Lee, Sharifah Emilia Tuan Sharif · 2023 · Human Pathology Reports
98. Intercellular Interactions in the Tumor Stroma and Their Role in Oncogenesis
    Nataliya A. Lunina, Dina R. Safina · 2022 · Molecular Genetics Microbiology and Virology
99. Construction of a novel nomogram based on competing endogenous RNAs and tumor-infiltrating immune cells for prognosis prediction in elderly patients with colorectal cancer
    Zhimin Tao, Bo Li, Chunyan Kang, Wei Wang, Xianzhe Li, Yaowu Du · 2023 · Discover Oncology
100. A expressão dos marcadores de transição epitélio-mesenquimal SNAI1 e o ZEB1 resulta em alterações transcricionais para promover progressão tumoral e evasão imune no câncer de próstata
     Luiz Paulo Chaves · 2023